TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 19.51%46.03B | 40.65%27.35B | -7.19%9.91B | 12.89%55.62B | 15.99%38.51B | -3.74%19.45B | 7.73%10.68B | 36.34%49.27B | 26.56%33.21B | --20.2B |
Operating income | 19.51%46.03B | 40.65%27.35B | -7.19%9.91B | 12.89%55.62B | 15.99%38.51B | -3.74%19.45B | 7.73%10.68B | 36.34%49.27B | 26.56%33.21B | 20.2B |
Cost of sales | -13.89%-41.84B | -31.14%-25.18B | 10.40%-9.42B | -19.13%-52.57B | -28.10%-36.74B | -10.24%-19.2B | -24.23%-10.51B | -50.52%-44.12B | -35.85%-28.68B | ---17.42B |
Operating expenses | -13.89%-41.84B | -31.14%-25.18B | 10.40%-9.42B | -19.13%-52.57B | -28.10%-36.74B | -10.24%-19.2B | -24.23%-10.51B | -50.52%-44.12B | -35.85%-28.68B | -17.42B |
Gross profit | 136.03%4.18B | 773.22%2.18B | 200.53%487.73M | -40.67%3.05B | -60.80%1.77B | -91.06%249.25M | -88.78%162.29M | -24.59%5.14B | -11.71%4.52B | 2.79B |
Selling expenses | -21.89%-10.86B | -27.38%-6.75B | -22.52%-3B | -22.28%-12.88B | -27.14%-8.91B | -23.39%-5.3B | -21.40%-2.45B | -53.20%-10.54B | -55.09%-7.01B | ---4.3B |
Research and development expenses | 0.61%-9.4B | 5.26%-6.08B | 6.87%-2.86B | -23.95%-13.43B | -37.98%-9.46B | -64.15%-6.42B | -74.58%-3.08B | -135.99%-10.84B | -148.09%-6.86B | ---3.91B |
Special items of operating profit | -57.87%239.58M | -80.11%57.18M | -108.40%-20.79M | 3.44%608.98M | 29.64%568.68M | -25.72%287.51M | 75.48%247.4M | 286.69%588.73M | 298.22%438.67M | --387.06M |
Operating profit | 1.18%-15.84B | 5.21%-10.6B | -5.52%-5.39B | -44.85%-22.66B | -80.02%-16.03B | -122.20%-11.19B | -133.56%-5.11B | -247.86%-15.64B | -334.12%-8.9B | -5.03B |
Financing cost | -129.83%-550.78M | -129.66%-347.02M | -148.86%-170.88M | -21.10%-403.53M | 1.22%-239.65M | -6.37%-151.1M | 11.22%-68.66M | 47.72%-333.22M | 56.79%-242.62M | ---142.05M |
Special items of earning before tax | 21.52%1.15B | 28.29%728.84M | -13.66%387.36M | 63.32%2.6B | 76.91%945.47M | -14.54%568.13M | -12.68%448.65M | 37.35%1.59B | -28.56%534.44M | --664.76M |
Earning before tax | 0.53%-15.24B | 5.08%-10.22B | -9.42%-5.18B | -42.25%-20.46B | -77.92%-15.32B | -138.70%-10.77B | -170.05%-4.73B | -261.84%-14.38B | -361.93%-8.61B | -4.51B |
Tax | -69.11%-47.27M | 65.80%-9.01M | 8.91%-6.99M | -373.36%-260.84M | 27.02%-27.96M | 8.10%-26.35M | 74.81%-7.67M | -30.38%-55.1M | -324.78%-38.31M | ---28.67M |
After-tax profit from continuing operations | 0.40%-15.29B | 5.23%-10.23B | -9.39%-5.18B | -43.52%-20.72B | -77.46%-15.35B | -137.77%-10.8B | -165.87%-4.74B | -259.40%-14.44B | -361.75%-8.65B | -4.54B |
Earning after tax | 0.40%-15.29B | 5.23%-10.23B | -9.39%-5.18B | -43.52%-20.72B | -77.46%-15.35B | -137.77%-10.8B | -165.87%-4.74B | -259.40%-14.44B | -361.75%-8.65B | -4.54B |
Minority profit | 16.57%235.69M | 18.00%153.73M | 14.43%73.34M | 249.20%427.21M | 229.49%202.19M | 336.22%130.28M | 51.25%64.1M | -98.13%122.34M | -99.06%61.36M | --29.87M |
Profit attributable to shareholders | 0.18%-15.53B | 4.95%-10.38B | -9.46%-5.26B | -45.25%-21.15B | -78.53%-15.55B | -139.07%-10.93B | -163.21%-4.8B | -37.71%-14.56B | -3.80%-8.71B | -4.57B |
Basic earnings per share | 18.51%-7.57 | 23.41%-5.07 | 11.68%-2.57 | -39.93%-12.44 | -74.30%-9.29 | -136.43%-6.62 | -159.82%-2.91 | -32.29%-8.89 | 0.74%-5.33 | -2.8 |
Diluted earnings per share | 18.51%-7.57 | 23.41%-5.07 | 11.68%-2.57 | -39.93%-12.44 | -74.30%-9.29 | -136.43%-6.62 | -159.82%-2.91 | -32.29%-8.89 | 0.74%-5.33 | -2.8 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.